Supply Chain Delays Marred Pfizer's Initial Vaccine Rollout Plans, But The Company Says It Will Still Deliver On The Supply It Promised The US
Dec 04, 2020
2  Likes 0 Comments
About this Deal
The Wall Street Journal reported Pfizer cut the number of vaccines it planned to ship in 2020 due to supply chain delays.
Sources told the WSJ that Pfizer sourced materials and set up supply chains while developing a vaccine, an "unprecedented" move.
But Pfizer and BioNtech maintain they will produce 1.3 billion doses by the end of 2021, making up for this year's shortfall by ramping up production.
Moncef Slaoui, the chief advisor overseeing COVID-19 vaccine distribution with the Trump administration, told CNBC's Meg Tirrell there is no change to Pfizer's vaccine commitment to the US.
Read the full article here